Showing results (61-70 of 108) with videos related to

Sort By:
Pageof 11
International Wound Journal|May 4, 2023
Perilesional injections of human platelet lysate versus platelet poor plasma for the treatment of diabetic foot ulcers: A double-blinded prospective clinical trialHussam Alhawari, Hanan Jafar, Mohammad Al Soudi, et al.
Blood Pressure|June 2, 2024
Discovering a novel genetic variant in 11 family members who had isolated pheochromocytoma linked to von Hippel-Lindau (VHL) syndrome, aligning with the type 2c phenotypeHussein Alhawari, Zaina Obeidat, Lina Wahbeh, et al.
Molecules (Basel, Switzerland)|February 11, 2023
Phytochemical Analysis and Anticancer Properties of <i>Drimia maritima</i> Bulb Extracts on Colorectal Cancer CellsKhairallah Al-Abdallat, Maher Obeidat, Nidaa A Ababneh, et al.
Plos One|May 8, 2019
hPL promotes osteogenic differentiation of stem cells in 3D scaffoldsHanan Jafar, Duaa Abuarqoub, Nidaa Ababneh, et al.
Leukemia Research|August 7, 2010
Relationship of serum imatinib trough level and response in CML patients: long term follow-upAbdalla Awidi, Ayed O Ayed, Nazzal Bsoul, et al.
European Journal of Pharmacology|May 27, 2021
siRNA: Mechanism of action, challenges, and therapeutic approachesWalhan Alshaer, Hadil Zureigat, Arwa Al Karaki, et al.
Interdisciplinary Toxicology|March 25, 2020
Genotoxicity of cisplatin and carboplatin in cultured human lymphocytes: a comparative studyBelal Azab, Anood Alassaf, Abdulrahman Abu-Humdan, et al.
Stem Cells and Development|October 24, 2024
Safety and Potential Efficacy of Expanded Umbilical Cord-Derived Mesenchymal Stromal Cells in Luminal Ulcerative Colitis PatientsHanan Jafar, Dana Alqudah, Reem Rahmeh, et al.
Breast Cancer (Tokyo, Japan)|April 25, 2020
Enhancing chemosensitivity of wild-type and drug-resistant MDA-MB-231 triple-negative breast cancer cell line to doxorubicin by silencing of STAT 3, Notch-1, and β-catenin genesArwa Alkaraki, Walhan Alshaer, Suha Wehaibi, et al.
Stem Cell Research|October 26, 2024
Establishment of a human induced pluripotent stem cell (iPSC) line (JUCTCi018-A) from a patient with Charcot-Marie-Tooth disease type 2EE (CMT2EE) due to a homozygous c.122G > A p.(Arg41Gln) mutation in the MPV17 geneNidaa A Ababneh, Raghda Barham, Ban Al-Kurdi, et al.
Pageof 11